(Q54331027)

English

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

scientific article published in February 1990

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

Juan Carlos García-Pagan

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

author name string

M Navasa

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

J Bosch

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

C Bru

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

P Pizcueta

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

J Rodés

6

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

language of work or name

0 references

publication date

1 February 1990

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

11

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

230-238

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

Tolerance to organic nitrates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

21 January 2018

Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

21 January 2018

Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term effects of propranolol on portal venous pressure

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled Trial of Propranolol for the Prevention of Recurrent Variceal Hemorrhage in Patients with Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic evaluation of the patient with portal hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulsed Doppler flow as a criterion of portal venous velocity: comparison with cineangiographic measurements

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic effects of a clonidine-induced decrease in sympathetic tone in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

SYMPATHETIC TONE MODULATES PORTAL VENOUS PRESSURE IN ALCOHOLIC CIRRHOSIS

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotonergic mechanisms in portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term hemodynamic effects of ketanserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis. Pharmacokinetic-hemodynamic interactions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect and mechanism of action of isosorbide-5-mononitrate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: comparison with the effects on portal pressure

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Portal hemodynamics during nitroglycerin administration in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840110212

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.1840110212

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/2307401

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54331027&oldid=1457930639"